| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Fusion Protein:ADCY9-NMRAL1 |
Fusion Protein Summary |
 Fusion gene summary |
| Fusion partner gene information | Fusion gene name: ADCY9-NMRAL1 | FusionPDB ID: 2263 | FusionGDB2.0 ID: 2263 | Hgene | Tgene | Gene symbol | ADCY9 | NMRAL1 | Gene ID | 115 | 57407 |
| Gene name | adenylate cyclase 9 | NmrA like redox sensor 1 | |
| Synonyms | AC9|ACIX | HSCARG|SDR48A1 | |
| Cytomap | 16p13.3 | 16p13.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | adenylate cyclase type 9ATP pyrophosphate-lyase 9adenylate cyclase type IXadenylyl cyclase 9type IX ATP pyrophosphate-lyase | nmrA-like family domain-containing protein 1NmrA-like family domain containing 1epididymis secretory sperm binding proteinshort chain dehydrogenase/reductase family 48A, member 1 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | O60503 | Q9HBL8 | |
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000294016, ENST00000571889, | ENST00000572391, ENST00000283429, ENST00000404295, ENST00000574425, ENST00000574733, |
| Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 27 X 12 X 11=3564 | 4 X 3 X 4=48 |
| # samples | 27 | 4 | |
| ** MAII score | log2(27/3564*10)=-3.72246602447109 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context (manual curation of fusion genes in FusionPDB) | PubMed: ADCY9 [Title/Abstract] AND NMRAL1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ADCY9(4163751)-NMRAL1(4519466), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | ADCY9-NMRAL1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ADCY9-NMRAL1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ADCY9-NMRAL1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ADCY9-NMRAL1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | ADCY9 | GO:0006171 | cAMP biosynthetic process | 9628827|10987815 |
| Hgene | ADCY9 | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 9628827 |
| Fusion gene breakpoints across ADCY9 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across NMRAL1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
Top |
Fusion Gene Sample Information |
| Fusion gene information from FusionGDB2.0. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | LGG | TCGA-DB-A64L-01A | ADCY9 | chr16 | 4163751 | - | NMRAL1 | chr16 | 4519466 | - |
Top |
Fusion ORF Analysis |
| Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000294016 | ADCY9 | chr16 | 4163751 | - | ENST00000283429 | NMRAL1 | chr16 | 4519466 | - | 3192 | 2232 | 539 | 3091 | 850 |
| ENST00000294016 | ADCY9 | chr16 | 4163751 | - | ENST00000574733 | NMRAL1 | chr16 | 4519466 | - | 3181 | 2232 | 539 | 3091 | 850 |
| ENST00000294016 | ADCY9 | chr16 | 4163751 | - | ENST00000404295 | NMRAL1 | chr16 | 4519466 | - | 3178 | 2232 | 539 | 3091 | 850 |
| ENST00000294016 | ADCY9 | chr16 | 4163751 | - | ENST00000574425 | NMRAL1 | chr16 | 4519466 | - | 3177 | 2232 | 539 | 3091 | 850 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000294016 | ENST00000283429 | ADCY9 | chr16 | 4163751 | - | NMRAL1 | chr16 | 4519466 | - | 0.007682542 | 0.99231744 |
| ENST00000294016 | ENST00000574733 | ADCY9 | chr16 | 4163751 | - | NMRAL1 | chr16 | 4519466 | - | 0.007588452 | 0.99241155 |
| ENST00000294016 | ENST00000404295 | ADCY9 | chr16 | 4163751 | - | NMRAL1 | chr16 | 4519466 | - | 0.007558711 | 0.9924413 |
| ENST00000294016 | ENST00000574425 | ADCY9 | chr16 | 4163751 | - | NMRAL1 | chr16 | 4519466 | - | 0.007658022 | 0.992342 |
Top |
Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >2263_2263_1_ADCY9-NMRAL1_ADCY9_chr16_4163751_ENST00000294016_NMRAL1_chr16_4519466_ENST00000283429_length(amino acids)=850AA_BP=564 MASPPHQQLLHHHSTEVSCDSSGDSNSVRVKINPKQLSSNSHPKHCKYSISSSCSSSGDSGGVPRRVGGGGRLRRQKKLPQLFERASSRW WDPKFDSVNLEEACLERCFPQTQRRFRYALFYIGFACLLWSIYFAVHMRSRLIVMVAPALCFLLVCVGFFLFTFTKLYARHYAWTSLALT LLVFALTLAAQFQVLTPVSGRGDSSNLTATARPTDTCLSQVGSFSMCIEVLFLLYTVMHLPLYLSLCLGVAYSVLFETFGYHFRDEACFP SPGAGALHWELLSRGLLHGCIHAIGVHLFVMSQVRSRSTFLKVGQSIMHGKDLEVEKALKERMIHSVMPRIIADDLMKQGDEESENSVKR HATSSPKNRKKKSSIQKAPIAFRPFKMQQIEEVSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEETKCEKISTLGDCYYCVAG CPEPRADHAYCCIEMGLGMIKAIEQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVWSNDVNLANLMEQLGVAGKVHISEATAKYLD DRYEMEDGKVIERLGQSVVADQLKGAQGGSVARTLLEDGTFKVRVVTRNPRKKAAKELRLQGAEVVQGDQDDQVIMELALNGAYATFIVT NYWESCSQEQEVKQGKLLADLARRLGLHYVVYSGLENIKKLTAGRLAAAHFDGKGEVEEYFRDIGVPMTSVRLPCYFENLLSHFLPQKAP DGKSYLLSLPTGDVPMDGMSVSDLGPVVLSLLKMPEKYVGQNIGLSTCRHTAEEYAALLTKHTRKVVHDAKMTPEDYEKLGFPGARDLAN -------------------------------------------------------------- >2263_2263_2_ADCY9-NMRAL1_ADCY9_chr16_4163751_ENST00000294016_NMRAL1_chr16_4519466_ENST00000404295_length(amino acids)=850AA_BP=564 MASPPHQQLLHHHSTEVSCDSSGDSNSVRVKINPKQLSSNSHPKHCKYSISSSCSSSGDSGGVPRRVGGGGRLRRQKKLPQLFERASSRW WDPKFDSVNLEEACLERCFPQTQRRFRYALFYIGFACLLWSIYFAVHMRSRLIVMVAPALCFLLVCVGFFLFTFTKLYARHYAWTSLALT LLVFALTLAAQFQVLTPVSGRGDSSNLTATARPTDTCLSQVGSFSMCIEVLFLLYTVMHLPLYLSLCLGVAYSVLFETFGYHFRDEACFP SPGAGALHWELLSRGLLHGCIHAIGVHLFVMSQVRSRSTFLKVGQSIMHGKDLEVEKALKERMIHSVMPRIIADDLMKQGDEESENSVKR HATSSPKNRKKKSSIQKAPIAFRPFKMQQIEEVSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEETKCEKISTLGDCYYCVAG CPEPRADHAYCCIEMGLGMIKAIEQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVWSNDVNLANLMEQLGVAGKVHISEATAKYLD DRYEMEDGKVIERLGQSVVADQLKGAQGGSVARTLLEDGTFKVRVVTRNPRKKAAKELRLQGAEVVQGDQDDQVIMELALNGAYATFIVT NYWESCSQEQEVKQGKLLADLARRLGLHYVVYSGLENIKKLTAGRLAAAHFDGKGEVEEYFRDIGVPMTSVRLPCYFENLLSHFLPQKAP DGKSYLLSLPTGDVPMDGMSVSDLGPVVLSLLKMPEKYVGQNIGLSTCRHTAEEYAALLTKHTRKVVHDAKMTPEDYEKLGFPGARDLAN -------------------------------------------------------------- >2263_2263_3_ADCY9-NMRAL1_ADCY9_chr16_4163751_ENST00000294016_NMRAL1_chr16_4519466_ENST00000574425_length(amino acids)=850AA_BP=564 MASPPHQQLLHHHSTEVSCDSSGDSNSVRVKINPKQLSSNSHPKHCKYSISSSCSSSGDSGGVPRRVGGGGRLRRQKKLPQLFERASSRW WDPKFDSVNLEEACLERCFPQTQRRFRYALFYIGFACLLWSIYFAVHMRSRLIVMVAPALCFLLVCVGFFLFTFTKLYARHYAWTSLALT LLVFALTLAAQFQVLTPVSGRGDSSNLTATARPTDTCLSQVGSFSMCIEVLFLLYTVMHLPLYLSLCLGVAYSVLFETFGYHFRDEACFP SPGAGALHWELLSRGLLHGCIHAIGVHLFVMSQVRSRSTFLKVGQSIMHGKDLEVEKALKERMIHSVMPRIIADDLMKQGDEESENSVKR HATSSPKNRKKKSSIQKAPIAFRPFKMQQIEEVSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEETKCEKISTLGDCYYCVAG CPEPRADHAYCCIEMGLGMIKAIEQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVWSNDVNLANLMEQLGVAGKVHISEATAKYLD DRYEMEDGKVIERLGQSVVADQLKGAQGGSVARTLLEDGTFKVRVVTRNPRKKAAKELRLQGAEVVQGDQDDQVIMELALNGAYATFIVT NYWESCSQEQEVKQGKLLADLARRLGLHYVVYSGLENIKKLTAGRLAAAHFDGKGEVEEYFRDIGVPMTSVRLPCYFENLLSHFLPQKAP DGKSYLLSLPTGDVPMDGMSVSDLGPVVLSLLKMPEKYVGQNIGLSTCRHTAEEYAALLTKHTRKVVHDAKMTPEDYEKLGFPGARDLAN -------------------------------------------------------------- >2263_2263_4_ADCY9-NMRAL1_ADCY9_chr16_4163751_ENST00000294016_NMRAL1_chr16_4519466_ENST00000574733_length(amino acids)=850AA_BP=564 MASPPHQQLLHHHSTEVSCDSSGDSNSVRVKINPKQLSSNSHPKHCKYSISSSCSSSGDSGGVPRRVGGGGRLRRQKKLPQLFERASSRW WDPKFDSVNLEEACLERCFPQTQRRFRYALFYIGFACLLWSIYFAVHMRSRLIVMVAPALCFLLVCVGFFLFTFTKLYARHYAWTSLALT LLVFALTLAAQFQVLTPVSGRGDSSNLTATARPTDTCLSQVGSFSMCIEVLFLLYTVMHLPLYLSLCLGVAYSVLFETFGYHFRDEACFP SPGAGALHWELLSRGLLHGCIHAIGVHLFVMSQVRSRSTFLKVGQSIMHGKDLEVEKALKERMIHSVMPRIIADDLMKQGDEESENSVKR HATSSPKNRKKKSSIQKAPIAFRPFKMQQIEEVSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEETKCEKISTLGDCYYCVAG CPEPRADHAYCCIEMGLGMIKAIEQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVWSNDVNLANLMEQLGVAGKVHISEATAKYLD DRYEMEDGKVIERLGQSVVADQLKGAQGGSVARTLLEDGTFKVRVVTRNPRKKAAKELRLQGAEVVQGDQDDQVIMELALNGAYATFIVT NYWESCSQEQEVKQGKLLADLARRLGLHYVVYSGLENIKKLTAGRLAAAHFDGKGEVEEYFRDIGVPMTSVRLPCYFENLLSHFLPQKAP DGKSYLLSLPTGDVPMDGMSVSDLGPVVLSLLKMPEKYVGQNIGLSTCRHTAEEYAALLTKHTRKVVHDAKMTPEDYEKLGFPGARDLAN -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr16:4163751/chr16:4519466) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ADCY9 | NMRAL1 |
| FUNCTION: Adenylyl cyclase that catalyzes the formation of the signaling molecule cAMP in response to activation of G protein-coupled receptors (PubMed:9628827, PubMed:12972952, PubMed:15879435, PubMed:10987815). Contributes to signaling cascades activated by CRH (corticotropin-releasing factor), corticosteroids and beta-adrenergic receptors (PubMed:9628827). {ECO:0000269|PubMed:10987815, ECO:0000269|PubMed:12972952, ECO:0000269|PubMed:15879435, ECO:0000269|PubMed:9628827}. | FUNCTION: Redox sensor protein. Undergoes restructuring and subcellular redistribution in response to changes in intracellular NADPH/NADP(+) levels. At low NADPH concentrations the protein is found mainly as a monomer, and binds argininosuccinate synthase (ASS1), the enzyme involved in nitric oxide synthesis. Association with ASS1 impairs its activity and reduces the production of nitric oxide, which subsecuently prevents apoptosis. Under normal NADPH concentrations, the protein is found as a dimer and hides the binding site for ASS1. The homodimer binds one molecule of NADPH. Has higher affinity for NADPH than for NADP(+). Binding to NADPH is necessary to form a stable dimer. {ECO:0000269|PubMed:17496144, ECO:0000269|PubMed:18263583, ECO:0000269|PubMed:19254724}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 394_521 | 564.3333333333334 | 1354.0 | Domain | Guanylate cyclase 1 |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 399_404 | 564.3333333333334 | 1354.0 | Nucleotide binding | ATP |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 441_443 | 564.3333333333334 | 1354.0 | Nucleotide binding | ATP |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 139_141 | 564.3333333333334 | 1354.0 | Topological domain | Extracellular |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 163_171 | 564.3333333333334 | 1354.0 | Topological domain | Cytoplasmic |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 193_215 | 564.3333333333334 | 1354.0 | Topological domain | Extracellular |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 1_117 | 564.3333333333334 | 1354.0 | Topological domain | Cytoplasmic |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 236_241 | 564.3333333333334 | 1354.0 | Topological domain | Cytoplasmic |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 260_280 | 564.3333333333334 | 1354.0 | Topological domain | Extracellular |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 118_138 | 564.3333333333334 | 1354.0 | Transmembrane | Helical |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 142_162 | 564.3333333333334 | 1354.0 | Transmembrane | Helical |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 172_192 | 564.3333333333334 | 1354.0 | Transmembrane | Helical |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 216_235 | 564.3333333333334 | 1354.0 | Transmembrane | Helical |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 242_259 | 564.3333333333334 | 1354.0 | Transmembrane | Helical |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 281_301 | 564.3333333333334 | 1354.0 | Transmembrane | Helical |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000283429 | 1 | 6 | 11_16 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000283429 | 1 | 6 | 155_158 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000283429 | 1 | 6 | 37_41 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000283429 | 1 | 6 | 58_59 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000283429 | 1 | 6 | 79_81 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000404295 | 1 | 6 | 11_16 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000404295 | 1 | 6 | 155_158 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000404295 | 1 | 6 | 37_41 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000404295 | 1 | 6 | 58_59 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000404295 | 1 | 6 | 79_81 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000574425 | 1 | 6 | 11_16 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000574425 | 1 | 6 | 155_158 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000574425 | 1 | 6 | 37_41 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000574425 | 1 | 6 | 58_59 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000574425 | 1 | 6 | 79_81 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000574733 | 1 | 6 | 11_16 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000574733 | 1 | 6 | 155_158 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000574733 | 1 | 6 | 37_41 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000574733 | 1 | 6 | 58_59 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP | |
| Tgene | NMRAL1 | chr16:4163751 | chr16:4519466 | ENST00000574733 | 1 | 6 | 79_81 | 13.333333333333334 | 300.0 | Nucleotide binding | NADP |
| - Not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 1058_1198 | 564.3333333333334 | 1354.0 | Domain | Guanylate cyclase 2 |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 1185_1187 | 564.3333333333334 | 1354.0 | Nucleotide binding | ATP |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 1192_1196 | 564.3333333333334 | 1354.0 | Nucleotide binding | ATP |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 302_786 | 564.3333333333334 | 1354.0 | Topological domain | Cytoplasmic |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 808_818 | 564.3333333333334 | 1354.0 | Topological domain | Extracellular |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 840_867 | 564.3333333333334 | 1354.0 | Topological domain | Cytoplasmic |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 889_891 | 564.3333333333334 | 1354.0 | Topological domain | Extracellular |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 913_920 | 564.3333333333334 | 1354.0 | Topological domain | Cytoplasmic |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 942_975 | 564.3333333333334 | 1354.0 | Topological domain | Extracellular |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 997_1353 | 564.3333333333334 | 1354.0 | Topological domain | Cytoplasmic |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 787_807 | 564.3333333333334 | 1354.0 | Transmembrane | Helical |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 819_839 | 564.3333333333334 | 1354.0 | Transmembrane | Helical |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 868_888 | 564.3333333333334 | 1354.0 | Transmembrane | Helical |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 892_912 | 564.3333333333334 | 1354.0 | Transmembrane | Helical |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 921_941 | 564.3333333333334 | 1354.0 | Transmembrane | Helical |
| Hgene | ADCY9 | chr16:4163751 | chr16:4519466 | ENST00000294016 | - | 2 | 11 | 976_996 | 564.3333333333334 | 1354.0 | Transmembrane | Helical |
Top |
Fusion Protein-Protein Interaction |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
| Gene | PPI interactors |
| Protein-protein interactors based on sequence similarity (STRING) |
| Gene | STRING network |
| ADCY9 | |
| NMRAL1 |
| - Retained interactions in fusion protein (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost interactions due to fusion (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to ADCY9-NMRAL1 |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ADCY9-NMRAL1 |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies